Drooid Logo
Back to story perspectives

Full Breakdown

NHS Secures Alternative Bone Cement Amid Supply Crisis

2/25/2026, 11:21:40 PM

Overview of the Supply Shortage

The National Health Service (NHS) in England has recently faced a significant supply shortage of bone cement, a critical material used in joint replacement surgeries. This shortage arose after Heraeus Medical, the NHS's primary supplier, experienced a packaging fault that halted production at its German facility. The disruption is expected to last for approximately two months, leading to concerns about delays in surgeries for hip and knee replacements, as well as other pre-planned procedures.

Impact on Surgical Procedures

Experts have warned that the shortage could affect the treatment of over 850,000 patients on waiting lists for joint-related surgeries, the largest backlog in any specialty within the NHS. The British Orthopaedic Association has advised hospitals to prioritize patients with urgent clinical needs while reviewing and managing waiting lists to maximize the use of available stock.

In response to the crisis, the NHS has secured two alternative products: Zimmer Biomet High Fatigue G and Johnson & Johnson CMW Smartset GHV Gentamicin. These alternatives have been clinically assured and are expected to provide sufficient supply for 10 to 12 weeks, with initial stocks already arriving in the UK.

Official Responses and Statements

Professor Tim Briggs of NHS England expressed relief at the acquisition of alternative bone cement, stating, "This shortage has been extremely concerning for patients and surgeons and we are delighted the NHS has now been able to secure this 'rescue package' of alternative bone cement to ensure trauma and elective care can continue across the country." Health Minister Zubir Ahmed also highlighted the importance of minimizing disruption, emphasizing the government's priority of addressing NHS waiting lists.

Buckinghamshire Healthcare NHS Trust has communicated its commitment to minimizing disruption, assuring patients that emergency and urgent trauma operations will proceed as planned. The Trust has stated, "We are taking all possible steps to minimize disruption and want to reassure our patients that emergency and urgent trauma operations will continue as normal."

Criticism and Concerns

Despite the proactive measures taken by the NHS, there remains concern among patients and healthcare providers about the potential impact of the supply shortage. The Trust has acknowledged the anxiety this situation may cause, particularly for those who have already faced long waits for surgery. They have committed to contacting affected patients directly to keep them informed about any changes to their planned care.

Conclusion and Next Steps

The NHS's swift action to source alternative bone cement aims to mitigate the impact of the supply crisis on surgical procedures. As the situation develops, hospitals will continue to prioritize patient needs and reschedule postponed operations. The NHS remains focused on ensuring that trauma and elective care can proceed without significant delays, while also addressing the backlog of patients awaiting treatment.